Zdrowie i gospodarka · 29.09.2016
Biosimilar User Fee Act; Public Meeting; Correction
The Food and Drug Administration is correcting a notice entitled "Biosimilar User Fee Act; Public Meeting" that appeared in the Federal Register of September 19, 2016 (81 FR 64171). The document announced a public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years (FYs) 2018 through 2022. The document was published with the incorrect date of the closure of the docket and incorrect transcript information. This document corrects those errors.